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Abstract
Objective. To estimate the annual number of injections per person in Sindh province of Pakistan and to describe their
distribution with regard to prescribers, settings, and safety.
Design. A population-based cross-sectional study in July–September 2001.
Setting. Lyari, an urban town in Karachi district; and Digri, a rural subdistrict in Mirpur Khas district.
Study participants. We selected a population-based cluster sample of 1150 individuals aged ≥3 months. We interviewed one
person per household for the number of encounters they had with health care providers, number and types of injections
received, safety circumstances, and cost of injections during the past 3 months.
Main outcome measure. The number of injections per person per year.
Results. After adjusting for age and sex, 68% of participants had received at least one injection in the previous 3 months (13.6
injections/person/year). The majority of the respondents received injections at the clinics of qualified general practitioners
(n = 571, 67%) by dispensers (644, 76%). Most of the injections (n = 3446, 96%) were for curative purposes. A freshly opened
syringe was used for only 454 (53%) of the injections. The average fee for receiving an injection was Rs. 51 (US$0.8).
Conclusion. Injections are overused in Pakistan’s Sindh province and the ratios of injection per capita that we found are
among the highest ever reported. Interventions are needed to substantially reduce injection prescription among private health
care providers who prescribe most of the injections received by the population.
Keywords: blood-borne pathogens, cluster analysis, equipment reuse, health care providers, health care surveys, injection
practices, Pakistan
Injections are the most frequent medical procedure per-
formed throughout the world. An estimated 16 billion injec-
tions are administered each year in developing and
transitional countries [1]. Various levels of injection use have
been reported worldwide ranging from 1.7 in Brazil to 13
injections per person per year in Mongolia [1,2].
Many injections in developing and transitional countries
are given with injection equipment that has been reused in the
absence of sterilization [1]. Reuse of injection equipment
transmits hepatitis B virus (HBV) [3,4], hepatitis C virus
(HCV) [5], HIV [6], and many other pathogens such as viral
haemorrhagic fever viruses [7,8]. As the number of injections
increases, the probability of exposure to infectious agents also
increases [9]. Interventions that reduce the frequency of
injection should therefore reduce transmission and save costs
associated with injection equipment, injectables, and out-of-
pocket providers’ fees. These interventions to decrease
injection use could be more successful if information were
available regarding injection use, distribution of injections
with regard to prescribers, providers, and determinants of
injection use.
Several reports suggest that injections are overused in
Pakistan [10–12]. Reuse of single-use injection equipment is
also common [11]. However, no population-based estimates
of injection frequency were available. Furthermore, no
information was available with respect to the distribution of
injections according to prescribers (e.g. MBBS) and injection
providers (e.g. nurses). To address these, we conducted a
survey to estimate the annual ratio of injection per capita in
Sindh province, Pakistan, to describe the distribution of
injections with respect to prescribers, injection providers,
types of injection and health care facility, and to estimate the
proportion of unsafe injections. We used WHO standardized
methodology to generate estimates of injection use so that
they could be compared with those reported in other
countries [13].
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Materials and methods
Study setting
We conducted a population-based cross-sectional survey
from July to September 2001 in an urban and a rural setting in
Pakistan’s Sindh province. We selected Lyari, an urban town
in Karachi (Pakistan’s largest city) with an ethnically diverse
population including Baloch, Punjabi, Mohajir, Pakhtoon,
and Sindhi. Lyari has a population of more than 600 000
people with an average household size of 6.5 persons and a
literacy rate of 67% [14]. Public health care facilities, general
practitioners (GPs) and private unqualified practitioners
provide health care. In contrast, Digri is a rural area in
Mirpurkhas district. It is located about 300 kilometres from
Karachi and comprises 294 000 people of Sindhi, Punjabi,
and Balochi descent living in scattered small villages. Its liter-
acy rate is lower than Lyari and agriculture is the primary
source of income [14]. People seek health care from few
qualified physicians at state-run Basic Health Units, private
unqualified practitioners, and GPs. These two settings were
selected conveniently as these house all the major ethnic
groups (Punjabi, Mohajir, Pakhtoon, Sindhi, and Baloch) of
Pakistan and hence the findings from the study may apply to
the areas of this population origin.
Design
We defined the survey population as individuals aged at least
3 months and residing for at least 3 months in the selected
localities. We used a cluster-sampling technique to select
study subjects. We defined a cluster as a group of people
living within specific administrative boundaries. These clearly
demarcated areas are called ‘sector’ in Lyari, and ‘deh’ in
Digri. We selected a total of 34 clusters: 17 clusters each from
133 available clusters in the rural area and 104 available clus-
ters in the urban area based on probability proportional to
size. Average number of houses in a cluster was 280 in the
rural area and 650 in the urban area. People living together
and sharing the same kitchen were considered as living in the
same household [15]. We used the households as sampling
units and individuals selected randomly from within house-
holds as sampling elements. Within each cluster, we selected
35 households using systematic sampling following the right-
hand rule with a random start from a central point and then
selected one person from each household using the lottery
method [15].
Trained interviewers fluent in the respondents’ primary
language interviewed participants or guardians of children
<15 years of age to collect information on encounters with
health care providers, ailment complaints, injection prescrib-
ers, injection providers, types of injection, safety circum-
stances, and cost of injections that were received during the
3 months preceding the interview. Injection was defined as a
procedure that pierces the skin or a mucosal membrane to
introduce a substance into the body. These injections
included those administered for immunization, therapeutic
(injections and infusions), or diagnostic purposes [16]. We
defined a physician as a person with basic medical qualifica-
tions (MBBS) and physicians working in the private sector as
GPs. We defined a dispenser as a person who dispenses med-
icine and provides the injection. Practitioners with no basic
medical qualifications (MBBS) were considered ‘unqualified
practitioners’. These practitioners work independently and
illegally at their clinics, prescribe and dispense medicine, and
administer injections.
We based sample size calculations on assumptions that
67% of the population received at least one injection during
the past year with 95% confidence level and 3% precision
[5,11]. After allowance for a design effect of 1.68 and 10%
non-response over the initial sample size of 621, we planned
for 1149 study subjects [15].
The Ethics Review Committee of Aga Khan University,
Pakistan approved the protocol. We explained the purpose of
the study to the subjects and obtained verbal informed
consent.
Statistical analysis
We double entered data in Epi Info software version 6.04 and
analysed it in Epi Info and Statistical Package for Social
Sciences (SPSS) version 10.0. We estimated annual ratios of
injections per capita and proportions of those who had
received at least one injection and adjusted these estimates for
the age and sex distribution of the population in the area as
standard obtained from the National Population Census,
1998 [14]. We obtained the annual ratio of injections per
capita by multiplying the average number of injections
received during 3 months by four. We calculated the overall
cost of an injection to patients by subtracting the reported
cost of visits during which no injection was administered
from the cost of visit during which an injection was adminis-
tered (the injection was paid for as part of the health care
visit). We performed cluster analysis to account for clustering
of injection practices at primary sampling unit level. We com-
puted intraclass correlation coefficients and design effects
and adjusted confidence interval and hypothesis testing for
design effect [17].
Results
We recruited 575 subjects in the urban and 575 in the rural
setting (total: 1150). In the urban and rural areas, eight and
five persons, respectively, refused to participate. We recruited
replacements from adjacent households. The mean age of the
study subjects was 25 years (SD: 18, median: 27 and range:
0.25–99 years); 873 (76%) were female. The proportion of
study subjects who had no formal schooling was 56% (n = 321)
and 75% (n = 424) in the urban and rural areas, respectively.
The major ethnic groups were Sindhi [60% (n = 343)] in rural
and Baloch [45% (n = 259)] in the urban setting. The median
monthly family income was Rs. 4000 (US$63, mean: Rs. 4825,
SD: Rs. 3538). Primary complaints on presentation to the
health care provider during the last visit included fever (32%),
body aches (13%), cough, flu, and sore throat (10%, Table 1).
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Injection frequency
In this sample 968 (84%) participants reported contact with a
health care provider during the previous 3 months. After
adjusting for age and sex, 68% (95% CI: 66–69%) of all
subjects (n = 1150) received at least one injection. The
proportion of those who reported receiving an injection was
slightly higher among those under 5 years of age (79%) than
among older age groups (60–76%, Table 2).
Table 1 Selected socio-demographic characteristics of the participants in injection use study in rural and urban settings of
Sindh province, Pakistan 2001
1Data collected as continuous variable and categorized later.
2Includes these who originated from parts of India not presently included in Pakistan.
3Income in Pakistani rupee, Rs. 65 = US$1 at the time of study.
4Complaints from the last visit only: complaints from the same system merged for ease of presentation.
Variables
.........................................
Urban
.........................................
Rural
.........................................
Total
n % n % n %
.........................................................................................................................................................................................................................
Sex
Female 441 77 432 75 873 76
Male 134 23 143 25 277 24
Age in years1
0.25–5 116 20 79 14 195 17
6–14 65 11 34 6 99 9
15–45 331 58 361 63 692 60
>45 63 11 101 17 164 14
Education (years of 
schooling)1
0 321 56 424 74 745 65
1–5 119 23 64 11 183 16
6–10 104 18 59 10 163 14
>10 31 5 28 5 59 5
Ethnicity
Sindhi 37 6 343 60 380 33
Punjabi 130 21 203 35 333 29
Baloch 259 45 1 0 260 23
Mohajir2 94 16 26 5 120 10
Pukhtoon 55 10 2 0 57 5
Family income3
<1500 29 5 133 23 162 14
1501–2500 59 10 88 15 147 13
2501–4000 223 39 119 21 342 30
4001–6000 153 27 88 15 241 21
>6000 110 19 146 26 256 22
Presenting complaint4
Fever 124 25 185 39 309 32
Body aches 85 17 38 8 123 13
Cough/sore throat 66 14 30 6 96 10
Gastrointestinal problem 40 8 36 8 76 8
Vaccination 4 1 66 14 70 7
Diarrhoea 43 9 18 4 61 6
Cardiovascular disease 36 7 14 3 50 5
Weakness 17 4 18 4 35 4
Gynaecological problem 19 4 13 3 32 3
Respiratory illness 21 4 10 2 31 3
Skin problem 11 2 19 4 30 3
Other 8 2 16 3 24 3
Renal colic 12 2 4 1 16 2
Surgery 6 1 7 1 13 1
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The crude ratio of injections per capita per year was 11.4
(median: 8, SD: 28, range: 0–372). The ratio standardized for
age and sex was 13.6 injections/person/year (Table 3). When
we excluded the upper 2% of frequency distribution (all those
receiving >60 injections per year) the age and sex standard-
ized annual ratio of injection per capita in urban strata, rural
strata and overall was 8.3, 7.3, and 8.2, respectively. In com-
parison with rural area residents, fewer urban area residents
reported receiving an injection (81% versus 65%, P < 0.001).
However, when the mean number of injections was consid-
ered, urban area residents reported receiving more injections
per capita than rural residents (14.6 versus 7.8, P = 0.004).
This difference was accounted for by a higher number of
injections per prescription in the urban area as well as a higher
mean number of visits to health care providers during the
previous 3 months (2.2 versus 1.2). Injection frequency also
differed significantly between ethnic groups (F-test = 7.7:
P < 0.001: data not shown). Baloch tribe people reported
receiving the highest (19.7 injections per person per year)
number of injections. The frequency of injection did not
differ between male and female (11.9 versus 11.3 per year:
P = 0.737). Most of those who presented for fever received
injections (n = 279/309: 90%) and a slightly smaller propor-
tion of those with other complaints also received injections
(n = 567/657: 87%); the difference was not significant
(P = 0.079). This suggests that injections are provided regard-
less of the presenting complaint and hence a large proportion
of these injections such as those provided for fever, flu, etc.
might not be necessary.
Types of injections
Of the 3585 injections administered during the previous
3 months, 96% were for therapeutic purposes (Table 4). The
proportion of injections administered for vaccination was higher
in the rural area (8%) than in the urban area (2%, P < 0.001).
Table 2 Proportion of subjects who received at least one injection during the previous 3 months by age group, Sindh pro-
vince, Pakistan 2001
.............................................
Urban (n = 575)
..............................................
Rural (n = 575)
...............................................
Overall (n = 1150)
n % n % n %
...........................................................................................................................................................................................................................
Age in years
0.25–5 116 74 79 100 195 79
6–14 65 74 34 84 99 76
15–45 331 57 361 77 692 60
>45 63 72 101 63 164 71
Total 575 65 575 81 1150 68
Table 3 Annual ratio of injections per capita by age groups in Sindh province, Pakistan 20011
95% CI: 95% confidence interval.
1Clustering of outcome allowed in estimation of confidence interval.
....................................................
Urban
.................................................
Rural
.....................................................
Overall
n Mean 95% CI n Mean 95% CI n Mean 95% CI
................................................................... ........... ....... ........................ ................ ................. ................ ....... ................ .................... ...............
Age: crude (years)
0.25–5 116 15.0 5.7–24.4 79 8.4 6.7–10.1 195 12.4 6.7–18.0
6–14 65 21.8 0.6–43.0 34 6.4 3.8–8.9 99 16.5 2.4–30.5
15–45 331 11.4 7.6–15.2 361 8.3 6.9–9.7 692 9.8 7.8–11.7
>45 63 23.9 3.3–44.5 101 8.2 4.7–11.7 164 14.2 5.9–22.6
Total 575 14.7 10.3–19.1 575 8.2 7.1–9.3 1150 11.4 9.2–13.7
Age and sex standardized
0.25–5 116 15.2 6.9–23.5 79 8.4 6.8–10.1 195 13.9 6.9–20.9
6–14 65 21.6 1.3–41.9 34 6.3 4.1–8.5 99 19.0 1.8–36.1
15–45 331 9.8 5.9–13.6 361 7.8 6.3–9.3 692 9.5 6.0–13.1
>45 63 18.8 5.1–32.6 101 10.0 4.2–15.8 164 17.7 5.0–30.4
Total 575 14.6 4.8–24.3 575 7.8 5.5–10.0 1150 13.6 4.9–22.2
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Injection prescribers and providers
GPs prescribed the majority of the injections received in the
urban [297 (75%)] and in the rural [238 (53%)] areas during
last visit. Dispensers were major providers of injections
(n = 644, 76%). GPs’ clinics were the major setting (n = 571,
67%) in which injections were provided. The private sector
provided a higher proportion of the injections in the urban
than in the rural area (91% versus 68%, P < 0.001). None of
the injections were provided by the patient him/herself, a
dentist, or a family member (Table 5).
Safety of injections
During the last contact with the provider, a new syringe,
defined as one opened in front of the patient was used for 191
(48%) and 263 (59%) injections in the urban and the rural
area, respectively. Overall, 454 (54%) of the patients had been
injected with freshly opened injection equipment (Table 6).
Of 82 vaccination injections during the last visit, 67 (82%)
were provided with a freshly opened syringe. In comparison
with providers at public facilities (n = 43/163, 26.4%),
unqualified practitioner (n = 244/508, 48%: OR = 5.2: 95%
CI: 2.7–9.8) and GP (n = 87/135, 64.1%: OR = 2.5: 95%
CI: 1.5–4.6) prescribed injections were more likely to have
been administered with a syringe of uncertain safety.
Cost of injections
The overall cost of an encounter with a health care provider
was Rs. 83 (US$1.3). This overall cost was Rs. 95 (US$1.5)
when an injection was prescribed and administered and Rs. 44
(US$0.7) without injection. The mean and median differences
between these two fees, Rs. 51 (US$0.8), Rs. 15 (US$0.2) were
significant (P < 0.001, Mann–Whitney U test).
Discussion
Our findings indicate that the frequency of injection in Sindh
province is one of the highest in the world [2,18]. Injection
use occurred mainly in the private sector where they are pre-
scribed by GPs and provided by unqualified dispensers. In
addition to being overused, injections are also unsafe. For
Table 4 Type of injections during previous 3 months in
Sindh province, Pakistan 2001
Injection type Urban 
(n = 2378)%
Rural 
(n = 1207)%
Overall 
(n = 3585)%
......................... ................................................................................
Therapeutic 
injection
95 88 92
Infusion 3 4 4
Vaccination 2 8 4
Table 5 Injection prescriber, provider, and setting for last injection received in Sindh province, Pakistan 2001
1A hakeem is a person who practises traditional medicine.
2Bone setters in the rural area, called ‘Phelwan’; some of them even have clinics.
3Practitioners having no basic medical degree such as MBBS.
Variables Urban (n = 395)% Rural (n = 453)% Total (n = 848)%
............................................................................................................................................................................................................................
Type of prescriber at last visit
Physician in private facility 75 53 63
Nurse in public facility 0 21 12
Unqualified practitioner 14 18 16
Physician in public facility 10 8 9
Hakeem/homeopath1 1 0 0
Chemist 0 0 0
Bone setter2 0 0 0
Injection provider at last visit
Dispenser 73 78 76
Physician 21 8 14
Unqualified practitioner3 6 14 10
Hakeem/homeopath1 0 0 0
Setting for last injection
GP clinic 89 54 67
Public dispensary/basic health unit 5 26 16
Unqualified practitioner’s clinic3 1 13 9
Public hospital 4 1 3
Private hospital 2 2 2
Home 0 4 2
Traditional healer clinic 0 0 0
N. Z. Janjua et al.
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only about half of injections that patient could recall had a
new freshly open syringe been used. This high number of
injections increases the risk of exposure to blood-borne
pathogens [9]. Thus, decreasing unnecessary injections is an
important component of any strategy to interrupt the
transmission of blood-borne pathogens in Pakistan, which is
facing an epidemic of hepatitis B and C [19].
Injection overuse has also been reported from other
countries. The highest frequencies of injections per person
has been reported from Romania, Moldova, and Mongolia,
with 5.3, 12.4, and 13 injections per person per year [2,18,20].
In these countries, injections are used in a formal public
health care setting, where they are prescribed by physicians
and administered by nurses. Outdated treatment protocols
often drive injection use in these countries, which used to fol-
low the biomedical model of the former Soviet Union. In
Africa, nurses prescribe and provide injections in the public
sector. In Uganda, nurses administer the majority of the 5.3
injections that on average each person receives each year [21].
In Africa outdated treatment guidelines and financial incen-
tive are key determinants of injection use. The introduction of
revised treatment protocols reduced injection use in Tanzania
[22]. In the state of Haryana, India, each person receives 2.5
injections each year. Injections are prescribed by GPs and
unqualified practitioners in the private setting [23]. However,
preliminary results of a nationwide assessment of injection
use suggest that these values are underestimated (N. K. Arora,
personal communication). Injections are overused because of
economic incentives [24]. Injections in Pakistan are pre-
scribed predominantly at GP clinics, where dispensers admin-
ister them. Injection administration is not driven by the old
treatment protocols (treatment protocols are not present or
prescribers are unqualified). Rather, economic incentives and
perception about patient preference for injection are key driv-
ers. Economic incentives play a key role: there is a difference
in cost of the visit for which injection is included and the cost
of a visit for which injection is not included. In addition, the
health care provider earns more when he reuses the syringe
for patients. Thus, efforts to decrease injection use should
address economic incentives for health care providers, espe-
cially for GPs and unqualified practitioners.
In Romania, Moldova, and Mongolia, an increase in the
supply of single-use injection equipment in the last 10 years
has reduced the reuse of injection equipment because it was
insufficient supply of injection equipment that drove
reuse[25]. Revision of treatment and sterilization guidelines
has been found to reduce injection use and improve sterility in
Tanzania [22]. In Pakistan, increasing injection equipment
supply may not have a major effect on reuse in the private sec-
tor, as single-use syringes are already available in the market at
tha low price of Rs. 2 (US$0.03). Thus, a number of other fac-
tors may explain unsafe injection practices including poor reg-
ulation of malpractice, economic incentives, lack of awareness
in the population, and poor consumer protection [26,27]. In
this situation, injection devices with reuse prevention features
including auto-disable syringes, may improve safety. Other
factors that could be beneficial include consumer empower-
ment through education to question the rationality of injec-
tion prescription and the safety of the syringe.
Injection practices in Pakistan are more similar to those in
other countries in South-East Asia, and in the eastern Medi-
terranean region. In Egypt, India, Nepal, Thailand, and Indo-
nesia injection use is also high. Most injections are
administered in the informal or the private sector and reuse is
common [1,23,28–30]. The predominant use of health care
from private and informal providers in these countries may
explain the injection practices similar to those observed in
Pakistan. Thus, attempts to improve injection safety must
give priority to the private sector in Pakistan and other coun-
tries of the region with similar practices. Since the private sec-
tor is not under the direct control of the government, their
practices may not have been regulated previously. Thus, more
efforts and programmes are needed to engage private provid-
ers in a dialogue on injection safety.
Our population sample included people who have been
hospitalized or are also diabetics. These individuals received
many injections. The distribution of injection frequency is
skewed towards the right in our sample, estimates without
Table 6 Safety circumstances of last injection received in Sindh Province, Pakistan 2001
1A syringe taken from a new packet whether provided at the clinic or brought by the patient in a closed packet was considered sterile.
2Water in the pot may not be boiling.
Safety circumstances Urban (n = 395)% Rural (n = 453)% Total (n = 848)%
..........................................................................................................................................................................................................................
Source of syringe
Newly opened, from the packet1 36 43 39
Newly opened brought by patient1 13 15 14
Behind the counter 15 21 18
Pot of water for boiling instruments2 28 0 13
Don’t know 7 15 11
Pot of tepid water 1 2 2
Picked from the table/tray 1 2 1
Syringe used on previous patient 0 2 1
Changed needle 1 0 1
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excluding upper 2% were 13.6 and after removal were 8.2.
This distribution of injections has important implications.
Firstly, in planning injection equipment supply needs, if esti-
mates include few high injection users, they will falsely
overestimate the injection equipment required at provincial or
national level. Secondly, these estimates should not be used
crudely in the mass action model for estimating transmission
the risk of blood-borne pathogens to the general population
as a high proportion of injections are clustered in a small
proportion of the population [9].
Our study had the following limitations. Firstly, in our study
sample the males in the age group 15–45 years and school-age
children were under-represented because we were able to visit a
household only once and these population groups were not
present at home during the day. To address the selection bias
we obtained age and sex standardized estimates for injection
frequency. Secondly, the cost of an injection cannot be meas-
ured accurately in population surveys, as it is aggregated in a
single fee that includes the consultation fee, drugs, and injec-
tions. While we tried to address this limitation by comparing
the cost of visits with injections and without injections, facility
surveys are a more appropriate method to estimate the compo-
nents of the cost of an injection more accurately. Thirdly, the
annual ratio of injections obtained by extrapolation of 3 month
recall may slightly overestimate immunization injections over
the year as well as overall estimates, since immunization injec-
tions may have been received once or twice during the study
period. Although this may not have major effect on overall esti-
mates, the findings should be used with caution. Fourthly, the
two communities are not a strictly statistically representative
sample from Sindh province or Pakistan.
Injections are overused in Sindh province of Pakistan to
administer medication and the number of injections per capita
that we found is among the highest ever reported. Such a high
frequency of injections needs the attention of the policy-
makers. The private sector, especially GPs, is a major contribu-
tor to this injection overuse. Thus, that sector should be the key
target of interventions to reduce injection frequency. Interven-
tions that address providers’ economic incentives may contrib-
ute more to reducing injection frequency. In addition,
interventions are needed to improve the safety of injections.
These include the introduction of injection devices that prevent
reuse, behavioural modification of providers, increasing aware-
ness in the population of risks associated with injection, creat-
ing consumer avoidance of injections and demand for safety.
The introduction of auto-disable devices may engage providers
in safer injection practices. Interventions that can be easily
translated and integrated into an already existing programme
may be more promising in reducing injection overuse. Further
research is needed to assess how many of the injections
administered are unnecessary and hence could be avoided.
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